Cognition Therapeutics, Inc.CGTXNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P64
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -0.50% |
| Q2 2025 | 43.07% |
| Q1 2025 | -17.84% |
| Q4 2024 | -22.35% |
| Q3 2024 | -14.24% |
| Q2 2024 | 17.21% |
| Q1 2024 | -32.77% |
| Q4 2023 | -31.12% |
| Q3 2023 | -12.58% |
| Q2 2023 | -36.64% |
| Q1 2023 | 73.44% |
| Q4 2022 | -254500.00% |
| Q3 2022 | 99.93% |
| Q2 2022 | -79.28% |
| Q1 2022 | -3058.42% |
| Q4 2021 | 104.93% |
| Q3 2021 | -125.27% |
| Q2 2021 | -17.88% |
| Q1 2021 | -60.83% |
| Q4 2020 | 50.05% |
| Q3 2020 | 61.90% |
| Q2 2020 | -575.85% |
| Q1 2020 | 0.00% |